• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Superior Laryngeal Nerve Block Safe, Effective for Treatment of Neurogenic Cough

by Linda Kossoff • June 17, 2024

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

CLINICAL QUESTION

How safe and effective is a superior laryngeal nerve (SLN) block for neurogenic cough?

You Might Also Like

  • Superior Laryngeal Nerve Block Improves Neurogenic Cough for Most
  • Superior Laryngeal Nerve Block May Be a Viable Treatment Option for Neurogenic Cough
  • Are Neuromodulating Medications Effective for Treatment of Chronic Neurogenic Cough?
  • Procedural Therapies Demonstrate Effectiveness in Improving the Lives of Patients with Neurogenic Cough
Explore This Issue
March 2024

BOTTOM LINE

An SLN block is a safe and efficacious procedure for the treatment of neurogenic cough.

BACKGROUND: Chronic cough is a common problem with a wide differential diagnosis. Some patients receive diagnoses of sensory neuropathy, or “neurogenic cough,” for which neuromodulating medications may be effective but carry significant side effects. Current data support the efficacy and safety of SLN blocks for neurogenic cough, but literature is limited.

STUDY DESIGN: Prospective placebo-controlled trial.

SETTING: Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina, Charleston, S.C.

SYNOPSIS: Researchers enrolled 19 adult patients with a history of neurogenic cough from an outpatient tertiary care center. Seventeen patients (15 females, average age 56.3 years) completed the study. Patients were randomized into treatment or placebo groups and given two unilateral injections at approximately two-week intervals. The treatment group received 1–2 mL of a 1:1 triamcinolone 40 mg: 1% lidocaine with 1:200,000 epinephrines; the placebo group received saline. Primary outcome measures included a yes/no answer to cough improvement, questionnaire, and daily visual analog scale. In the treatment group of 10 patients, eight reported symptom improvement with at least one injection. Only 50% of these patients reported a greater than 50% improvement, however. Authors noted that this left open the question of whether clinical differences existed for these patients. Two treatment group patients did not improve until the contralateral side was injected, indicating that neuropathy may affect one or both sides in patients with neurogenic cough. Only one person from the placebo group (n = 7) reported any improvement. There were no significant adverse effects. Study limitations included the small sample size.

Citation: Tipton CB, Walters R, Gudipudi R, et al. The efficacy of superior laryngeal nerve black for neurogenic cough: a placebo-controlled trial. Laryngoscope. 2023;133:3068–3074.

Filed Under: Laryngology, Laryngology, Literature Reviews, Practice Focus Tagged With: SLN, Superior Laryngeal Nerve BlockIssue: March 2024

You Might Also Like:

  • Superior Laryngeal Nerve Block Improves Neurogenic Cough for Most
  • Superior Laryngeal Nerve Block May Be a Viable Treatment Option for Neurogenic Cough
  • Are Neuromodulating Medications Effective for Treatment of Chronic Neurogenic Cough?
  • Procedural Therapies Demonstrate Effectiveness in Improving the Lives of Patients with Neurogenic Cough

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you invented or patented something that betters the field of otolaryngology?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists as Entrepreneurs: Transforming Patient Care And Practice

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Continued Discussion And Engagement Are Essential To How Otolaryngologists Are Championing DEI Initiatives In Medicine

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Leaky Pipes—Time to Focus on Our Foundations
    • You Are Among Friends: The Value Of Being In A Group
    • How To: Full Endoscopic Procedures of Total Parotidectomy
    • How To: Does Intralesional Steroid Injection Effectively Mitigate Vocal Fold Scarring in a Rabbit Model?
    • What Is the Optimal Anticoagulation in HGNS Surgery in Patients with High-Risk Cardiac Comorbidities?

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939